VGM & ASSOCIATESHealthcare MSO
Full Menu Search

S. 3069 Introduced Into Senate

Published in Government Relations on October 19, 2023

S. 3069 Introduced Into Senate

On Oct. 18, U.S. Senators Tammy Duckworth (D-IL) and Lisa Murkowski (R-AK) re-introduced legislation to ensure breast cancer patients and survivors who have experienced a mastectomy are able to access custom breast prosthetics under Medicare. The Breast Cancer Patient Equity Act would provide coverage for custom fabricated breast prostheses—which, unlike other prosthetic devices, are not currently covered by Medicare—to the more than 100,000 women who undergo mastectomies annually. 

“We can do so much more to help patients and survivors of breast cancer fully recover and achieve the best quality of life,” said Sen. Duckworth. “It is absurd that the breast is the only human body part not currently covered by Medicare as a customized replacement, which is one of the reasons why I’m proud to reintroduce this legislation with Senator Murkowski to finally change that and help expand access and options for women who have already been through so much.”

“Battling breast cancer is a traumatizing experience for the many women who go through it—and right now, many who undergo mastectomies have poor choices when it comes to reconstructive surgeries. That’s why I’m proud to join Senator Duckworth on the Breast Cancer Patient Equity Act, which would provide more choices for women who undergo mastectomies,” said Sen. Murkowski. “This bill will not just expand coverage under Medicare for thousands of women, but it will also aid in the emotional and physical healing for women who battled breast cancer.”

A copy of the bill text is available here.

"We’re fortunate to have such strong support from Sen. Duckworth and Sen. Murkowski. They understand there’s so much more to recovering from breast cancer than being done with chemotherapy and radiation treatment," said Nikki Jensen, vice president of Essentially Women. "Being able to move forward with the breast replacement option that’s most appropriate for the patient is an important part of recovery."

For most women, a flat-backed, off-the-shelf breast prosthesis will be suitable and fit well. However, after mastectomy surgery, not all women will have a flat chest wall to allow a good fit for off-the-shelf prosthesis. Further, it can be difficult for some women, particularly women of color, to find prostheses that match their skin tone.

In recent years, technological advancements have enabled the creation and precise fitting of custom breast prostheses. Custom prostheses are typically made from higher-end silicone products produced in a unique mold designed to fit the chest like a puzzle piece. Through laser scans of the chest, which may have bumps, scarring, or dips due to surgery, many women find that custom breast prostheses provide a superior fit and comfort. Unfortunately, these patients and survivors may struggle to access custom breast prostheses due to lack of coverage.

The need for grassroots advocates to step forward and ask their own senators and representatives in Congress to support this bicameral legislation is essential in ensuring that Medicare beneficiaries are able to select custom breast prosthesis if that’s the right choice for them.

Learn more and take action here

TAGS

  1. essentially women
  2. legislation
  3. let her decide
  4. mastectomy
  5. vgm government
  6. women's health

Get Connected

Stay up-to-date on the latest resources and news provided by VGM & Associates.

Sign Up for Email

From Our Experts

Proposed Rule Suggests Significant Change To Accreditation Process thumbnail Proposed Rule Suggests Significant Change To Accreditation Process The recently released proposed rule CMS-1828-P contains a significant change that could reshape how suppliers navigate accreditation. The rule proposes a major change that would require suppliers to be surveyed and reaccredited annually instead of the current three (3) year cadence. This proposal raises substantial questions about both operational feasibility and cost implications. August Of Action: Your Chance To Connect With Congress thumbnail August Of Action: Your Chance To Connect With Congress It's time to take advantage of August Of Action—a perfect opportunity to make your voice heard. Every summer, federal legislators return to their home states during the Congressional recess. While it gives them a break from Washington D.C., it's primarily a time for them to connect with constituents like you. HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry. CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk. Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review. Evaluating the Value of a Payer Contract thumbnail Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort. Webinar: Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT. The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement.

Be Part of Something Bigger

Become a Member